“showed a trend”

Plasma TMA levels of the Con + IMC group showed a trend of a decrease compared to the Con group (0.08 μM vs. 0.15 μM, p = 0.15, Supplemental Fig.

However, we found that the frequencies of CCR9 + CD4 + T cells in LPMC showed a trend ( P = 0.15) to be higher than their PBMC counterparts following Ty21a immunization ( Fig. 2B ).

The expression of CD146 showed a trend toward higher in ECs than in LCs ( p = 0.15).

However, the decrease in mean values observed in the visuospatial group only showed a trend ( p = 0.15).

Although the data only showed a trend towards a reduction ( p = 0.15), the blockade of NfL increase is further confirmed by the lack of difference between 2-month-old controls and the 5-month-old S1D12 mice.

White participants also showed a trend toward greater community involvement and leadership, B = 0.80, SE = 0.55, t (75) = 1.44, P = 0.15, d = 0.57, so the main effect of treatment was significant, B = 0.98, SE = 0.38, t (75) = 2.60, P = 0.01, d = 0.64, and the race × condition interaction was not, B = 0.35, SE = 0.75, t (75) = 0.47, P = 0.64.

SLC16A3 also showed a trend toward an inverse correlation with brain pH in controls (r = −0.49, p = 0.15) and a significant inverse correlation in SCZ (r = −0.65, p = 0.04), but not in BD (r = +0.49, p = 0.15).

Construction of a DNA Repair Pathway–Focused Score Kaplan–Meier log-rank P values were calculated to identify a subset of genes whose expression values showed a trend associated with overall survival (OS) ( P < .15) ( Supplementary Figure 1 , available online).

Non-HSCT GATA2-deficient patients showed a trend toward increased relative abundance of Proteobacteria compared with HD and post-HSCT patients ( p = 0.15 and p = 0.73, respectively; Figure 2 A,B).

Patients with carbapenem-resistant VARI had significantly greater ICU costs than patients with carbapenem-susceptible isolates (6053 USD (IQR 3806–7824) vs 3131 USD (IQR 2108–7551), p = 0.04) and after correction for adequacy of initial antibiotics and APACHE II score, showed a trend towards increased risk of in-hospital death (HR 2.82, 95% CI 0.75–6.75, p = 0.15).

On the other hand, the IRP rate of all the population including all histology showed a trend, without reaching statistical significance, to higher risk in males than females (25 out 194 males, 12.9%; and 4 out 62 females, 6.5%; P = 0.15).

Our data showed a trend of positive correlation (R 2 = 0.27, r = 0.5, p = 0.15) between [Fe] and FtH protein levels ( Figure 4 E).

In univariate analysis, those on abiraterone showed a trend toward increased risk for composite primary CV outcome [hazard ratio (HR) 1.17; 95% confidence interval (CI) 0.94-1.47; P = 0.15].

Some variables showed a trend toward association without reaching statistical significance, such as previous AHF episodes (OR 1.58; 95% CI 0.85–2.95; p = 0.15), respiratory rate >30 bpm (OR 2.08; 95% CI 0.65–6.61; p = 0.22), or hospital admission (OR 2.10; 95% CI 0.93–4.78; p = 0.08).

2 A), and showed a trend towards better overall survival (OS) (Log-rank test, P = 0.15) ( Fig. 2 B), although this difference did not reach statistical significance.

In multivariable analysis, larger LA diameter showed a trend toward an increased risk of new-onset AF (OR 1.10 per mm, 95% CI 0.97–1.25, p = 0.15) among patients without previous AF, whereas sex, age, common risk factors, or cardiomyopathy were not significant predictors.

Monotherapy with t-L-ALD showed a trend towards greater effectiveness than L-ALD (4.70 × 10 8 ± 1.78 × 10 8 vs. 1.24 × 10 9 ± 4.65 × 10 8 photons, day 27, p = 0.15).

However, ide‐cel patients with high baseline sVCAM‐1 or sIL‐2R showed a trend towards worse PFS (P = 0.15; P = 0.17) (Figure S7G,J ).

With respect to severe fibrosis, although serrated histology showed a trend toward lower rates of severe fibrosis, this association did not reach statistical significance in the multivariate analysis (OR: 0.49, 95% CI: 0.16–1.20, p = 0.15), likely due to the limited number of CSL cases presenting severe fibrosis in our cohort.

At 12 months, the treatment group showed a trend toward fewer ED visits than controls (33.8 versus 46.4%), p = 0.15.

The MED12 IP/Input ratio showed a trend of reduction (Fig. 4F ; p = 0.15), suggesting a potential weakening of the MED1-MED12 interaction following Med13l KO.

Statistical comparison of the correlation coefficient observed at baseline to that observed post stimulation showed a trend level decrease in correlation between these two time periods (Fischer’s z transform: z = 1.04, p = 0.15).

Inhibition in GS-cPass showed a trend towards positive association with VL, without reaching statistical significance (p = 0.15).

At a low concentration of 0.2 μM, CP96,345 showed a trend of inhibition (0.05 < P < 0.15) but at higher concentrations (5 μM), it completely abolished SP-induced up-regulation of PPTA/NK1R mRNA expression ( Fig. 2A and B).

Although mitotic activity and vascular invasion showed a trend toward higher levels in the high SETD5 expression group, these differences did not reach statistical significance ( p = 0.15 and p = 0.12, respectively). 3.4.